Mucolytic Agents and Statins Use is Associated with a Lower Risk of Acute Exacerbations in Patients with Bronchiectasis-Chronic Obstructive Pulmonary Disease Overlap

Background: Bronchiectasis-chronic obstructive pulmonary disease (COPD) overlap (BCO) is a neglected area of trials, and it is not covered by guidelines for clinical practice. Methods: Using the National Health Insurance Research Database of Taiwan, COPD patients with or without bronchiectasis from...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Vincent Yi-Fong, Perng, Diahn-Warng, Chou, Ting-Chun, Chou, Yueh-Ching, Chang, Yuh-Lih, Hsu, Chia-Chen, Chou, Chia-Lin, Lee, Hsin-Chen, Chen, Tzeng-Ji, Hu, Po-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306823/
https://www.ncbi.nlm.nih.gov/pubmed/30518165
http://dx.doi.org/10.3390/jcm7120517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306823/
https://www.ncbi.nlm.nih.gov/pubmed/30518165
http://dx.doi.org/10.3390/jcm7120517

Ejemplares similares